Loading...
•
Jun 30, 2023
Enfusion Q2 2023 Earnings Report
Enfusion reported a balanced quarter with revenue growth and improved profitability.
Key Takeaways
Enfusion reported a balanced quarter with a 16.9% year-over-year revenue growth, driven by increasing client add counts, bookings, and average contract value, despite macroeconomic challenges.
Signed a 20-billion-dollar active ETF fund manager and a public investment arm of a global private equity firm.
Delivered significant margin expansion through operational efficiencies and cost control.
Improved client add counts with 39 new clients, up from 27 in the previous quarter.
Increased average contract value and 2Q bookings growth increased 44% sequentially.
Revenue by Segment
Forward Guidance
Enfusion anticipates revenue between $170 million and $175 million, and adjusted EBITDA between $30 million and $32 million for 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...